HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers

Summary

To evaluate the safety, tolerability and pharmacokinetics of HEC53856 after single or multiple oral administration, as well as the food effect on the pharmacokinetics, in healthy non-elderly subjects.

Timeline

Start

2019-05-14

Primary completion

2020-01-01

Completion

2020-01-01

Drugs

Indications

No indication recorded.